Purple Biotech share price logo

Purple Biotech Share Price

NASDAQ: PPBT

Small Cap

$4.11

+0.11

(+2.75%)

as on

Purple Biotech Stock Performance

as on April 16, 2026 at 6:57 am IST

  • Day's Low

    Day's High

    $3.86
    $4.13
    downward going graph

    6.08%

    Downside

    0.49%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $3.60
    $29.40
    downward going graph

    12.41%

    Downside

    615.33%

    Upside

    downward going graph

Purple Biotech share price movements today

Previous Close
$4.00
Open
$3.96
Volume
532.3K
Day's Low - High
$3.86 - $4.13
52 Week Low - High
$3.60 - $29.40

Purple Biotech Historical Returns

1 Month Return
+ 0.49 %
3 Month Return
-35.07 %
1 Year Return
-83.63 %
3 Year Return
-98.96 %
5 Year Return
-99.47 %

Purple Biotech Stock Fundamentals & Key Indicators

Check Purple Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.3M

EPS (TTM)

-1.65

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-124.46%

Purple Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Purple Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$6.3M-99.47%NA0.00%
BUY$44.5B140.06%143.098.45%
BUY$112.4B101.33%28.8132.94%
NA$36.7BNA124.985.37%
BUY$79.7B50.01%18.1831.41%

Stock Returns calculator for Purple Biotech Stock including INR - Dollar returns

The Purple Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Purple Biotech investment value today

Current value as on today

₹17,842

Returns

-₹82,158

(-82.16%)

Returns from Purple Biotech Stock

-₹83,625 (-83.63%)

Dollar Impact

₹1,468 (+1.47%)

Purple Biotech Stock’s Investor Sentiment and Interest

Search interest for Purple Biotech Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-56% versus previous 30 day period

Purple Biotech Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
0
0
0
0
0
0
Operating Income
-5
-6
-4
-3
-2
-1
-1
-1
-1
-2
EBITDA
-4
-4
-3
-2
0
0
0
-1
-1
-2
Interest Expense
0
2
0
0
0
0
0
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-5
-4
-3
-2
0
0
0
-1
-1
-23
Income Tax Expense
0
1
0
0
-
-
-
-
-
-
Net Income
-5
-4
-3
-2
0
0
0
-1
-1
-23
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Purple Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
1
1
0
0
0
-
-
Gross Profit
0
1
0
0
0
0
0
0
0
Operating Income
-11
-7
-7
-13
-17
-22
-22
-11
-7
EBITDA
-12
-5
-6
-28
-17
-21
-19
-7
-6
Interest Expense
0
0
0
0
0
0
2
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-12
-5
-5
-28
-17
-21
-19
-7
-26
Income Tax Expense
0
0
0
-15
0
0
0
-
-
Net Income
-12
-5
-5
-27
-18
-21
0
-7
-26
Net Profit Margin
-12177.00%
-520.00%
-585.00%
-2799.90%
5745.00%
2381.10%
-10.15%
0.00%
0.00%

Purple Biotech Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-4
-3
-2
0
0
0
-1
-1
-23
Operating Cash Flow
-4
-5
-3
-3
-2
-1
-1
-1
-1
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
4
0
0
2
3
0
0
5
0
Change in Cash
0
-4
-3
-1
1
-1
-1
4
0

Purple Biotech Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-13
-5
-5
-28
-17
-21
-19
-7
-26
Operating Cash Flow
-8
-8
-5
-12
-15
-16
-19
-14
-5
Investing Cash Flow
2
2
0
-49
13
19
13
0
0
Financing Cash Flow
2
7
5
68
1
1
5
6
6
Change in Cash
-2
1
0
6
0
4
0
-7
1

Global Institutional Holdings in Purple Biotech

Funds
Holdings
SmartHarvest Portfolios, LLC
0.51%
GAMMA Investing LLC
0.01%
Royal Bank of Canada
0%
Northwestern Mutual Wealth Management Co
0%
Tradewinds Capital Management, LLC
0%

Purple Biotech News & Key Events

  • img

    Today's Timeline - 30 October

    Thu, 03:08 PM

    -

    PPBT shares dipped 19.1% in pre-market after an 82% jump due to achieving a commercially viable yield for IM1240.

    Thu, 09:03 PM

    -

    Purple Biotech's stock surged 81% after announcing a production milestone for IM1240, a tri-specific antibody targeting cancer.

Insights on Purple Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 63.5% return, outperforming this stock by 162.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 44.6% return, outperforming this stock by 128.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, PPBT stock has moved down by -83.6%

About Purple Biotech

Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its oncology pipeline includes CM24, a humanized monoclonal antibody that blocks the interactions of carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 2 clinical trial for the treatment of pancreatic ductal adenocarcinoma; NT219, a small molecule that targets and inhibits insulin receptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 2 clinical trials for the treatment recurrent and/or metastatic squamous cell carcinoma of the head and neck cancer or colorectal adenocarcinoma; and CAPTN-3 - IM1240 and IM1305, multi-valent antibody designed to activate anti-tumoral immune response against TAA positive tumors, which is in preclinical stage. The company has collaboration agreement with Bristol Myers Squibb Company to evaluate the combination of CM24 with the PD-1 inhibitor nivolumab in addition to chemotherapy. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. The company was incorporated in 1968 and is headquartered in Rehovot, Israel.
OrganisationPurple Biotech
Headquarters4 Oppenheimer Street, Rehovot, Israel, 7670104
IndustryBiotechnology
CEOMr. Gil Efron CPA, M.A.
E-voting on sharesClick here to vote

Key Management of Purple Biotech

Name

Title

Mr. Gil Efron CPA, M.A.

CEO & Director

Mr. Shai Lankry CPA, M.B.A.

Chief Financial Officer

Dr. Michael Schickler Ph.D.

Head of Clinical & Regulatory Affairs

FAQs

What is Purple Biotech share price today?

Purple Biotech share price today is $4.11 as on at the close of the market. Purple Biotech share today touched a day high of $4.13 and a low of $3.86.

What is the 52 week high and 52 week low for Purple Biotech share?

Purple Biotech share touched a 52 week high of $29.4 on and a 52 week low of $3.6 on . Purple Biotech stock price today i.e. is closed at $4.11,which is 86.02% down from its 52 week high and 14.16% up from its 52 week low.

What is Purple Biotech's market capitalisation today?

Purple Biotech market capitalisation is $0.00T as on .

How to invest in Purple Biotech Stock (PPBT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Purple Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Purple Biotech Shares that will get you 0.3650 shares as per Purple Biotech share price of $4.11 per share as on April 16, 2026 at 1:27 am IST.

What is the minimum amount required to buy Purple Biotech Stock (PPBT) from India?

Indian investors can start investing in Purple Biotech (PPBT) shares with as little as ₹93.289 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.89 in Purple Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Purple Biotech share’s latest price of $4.11 as on April 16, 2026 at 1:27 am IST, you will get 2.4331 shares of Purple Biotech. Learn more about fractional shares .

What are the returns that Purple Biotech has given to Indian investors in the last 5 years?

Purple Biotech stock has given -99.47% share price returns and 25.08% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?